0003-1611 : Baraclude 0.5 mg Oral Tablet


NDC0003-1611
Labeler: E.r. Squibb & Sons, L.L.C.
Product Type: Human Prescription Drug
Drug Name:  Baraclude
Dosage Form: Oral Tablet, Film Coated
Application #: NDA021797
Rev. Date: 


Appearance:


Markings: BMS;1611
Shapes:  Triangle (3 sides)
Colors:  White
Size (mm): 8
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

BMS 1611: (0003-1611) Baraclude 0.5 mg Oral Tablet by E.r. Squibb & Sons, L.L.C.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0003-1611-12: 1 BOTTLE IN 1 CARTON (0003‑1611‑12) > 30 TABLET, FILM COATED IN 1 BOTTLE
  • 0003-1611-13: 1 BOTTLE IN 1 CARTON (0003‑1611‑13) > 90 TABLET, FILM COATED IN 1 BOTTLE

Active Ingredients:

  • Entecavir

Dosage Strength:

  • .5 mg

Inactive Ingredients:

  • Lactose Monohydrate
  • Cellulose, Microcrystalline
  • Crospovidone
  • Povidone
  • Magnesium Stearate
  • Titanium Dioxide
  • Hypromelloses
  • Polyethylene Glycol 400
  • Polysorbate 80

Pharmaceutical Classes:

  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [EXT]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0003-1612 Baraclude 1 mg Oral Tablet by E.r. Squibb & Sons, L.L.C.
  • 0003-1614 Baraclude .05 mg/ml Oral Solution by E.r. Squibb & Sons, L.L.C.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0003-1611 QR Code

< Prev: 0003-1428Next: 0003-1612 >

Related Discussions:

Baraclude for liver cirrhosis
My brother-in-law has been sufferring from liver cirrhosis for the past two months. Is baraclude used for liver cirrhosi... 1 reply
entecavir
I am Hepqtitis b HBeAg-negative in october 2006 I started Peginterferon for 48 weeks virus load came zero after six mont... 1 reply




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.